Evidence map›Paper›PMID 34356669›Full record

ArticleBiomolecules2021

Enzymatic and Chemical Syntheses of Vacor Analogs of Nicotinamide Riboside, NMN and NAD.

Lars Jansen Sverkeli, Faisal Hayat, Marie E Migaud, Mathias Ziegler

Abstract read
In one paragraph

Article in Biomolecules, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Adaptation of a Commercial NADMolecules (Basel, Switzerland) · 2024
    Article
  6. Inhibitors of NADInternational journal of molecular sciences · 2024
    Review
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lars Jansen SverkeliDepartment of Biological Sciences, University of Bergen, 5007 Bergen, Norway.
Faisal HayatMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.
Marie E MigaudMitchell Cancer Institute, University of South Alabama, Mobile, AL 36604, USA.ORCID 0000-0002-9626-2405
Mathias ZieglerDepartment of Biomedicine, University of Bergen, 5009 Bergen, Norway.ORCID 0000-0001-6961-2396

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

It has recently been demonstrated that the rat poison vacor interferes with mammalian NAD metabolism, because it acts as a nicotinamide analog and is converted by enzymes of the NAD salvage pathway. Thereby, vacor is transformed into the NAD analog vacor adenine dinucleotide (VAD), a molecule that causes cell toxicity. Therefore, vacor may potentially be exploited to kill cancer cells. In this study, we have developed efficient enzymatic and chemical procedures to produce vacor analogs of NAD and nicotinamide riboside (NR). VAD was readily generated by a base-exchange reaction, replacing the nicotinamide moiety of NAD by vacor, catalyzed by

Indexed as

ADP-ribosyl CyclaseAnimalsAntineoplastic AgentsAplysiaCell ProliferationHEK293 CellsHumansNADNiacinamidePhenylurea CompoundsPhosphotransferases (Alcohol Group Acceptor)Pyridinium CompoundsADP-ribosyl CyclaseAntineoplastic AgentsNADNiacinamidenicotinamide-beta-ribosidenicotinamide riboside kinasePhenylurea CompoundsPhosphotransferases (Alcohol Group Acceptor)Pyridinium Compoundspyriminilbase exchangeNAD+vacorVorbruggen chemistry

Identifiers

PMID34356669
PMCPMC8301822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.